Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zheng Y et al. | Efficient biotransformation of polysialogangliosides for preparation of GM1 by Cellulosimicrobium sp. 21. | 2014 | Molecules | pmid:25299818 |
Morgan ML et al. | Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. | 2014 | J Neuroophthalmol | pmid:25062498 |
Bergante S et al. | Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells. | 2014 | J. Lipid Res. | pmid:24449473 |
Vachalová I et al. | Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia. | 2014 | Clin Neurol Neurosurg | pmid:24813327 |
Heredia V et al. | Interfacial stabilization of the antitumoral drug Paclitaxel in monolayers of GM1 and GD1a gangliosides. | 2015 | Biochim. Biophys. Acta | pmid:26119566 |
Koga M et al. | Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies. | 2015 | PLoS ONE | pmid:25867522 |
Wang Y et al. | Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-κB signaling pathways through TLR4. | 2015 | Int. Immunopharmacol. | pmid:26054879 |
Miklavcic JJ et al. | Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. | 2015 | World J. Gastroenterol. | pmid:26401073 |
Tsukamoto K et al. | CRISPR/Cas9-Mediated Genomic Deletion of the Beta-1, 4 N-acetylgalactosaminyltransferase 1 Gene in Murine P19 Embryonal Carcinoma Cells Results in Low Sensitivity to Botulinum Neurotoxin Type C. | 2015 | PLoS ONE | pmid:26177297 |
Xu X et al. | A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. | 2015 | Dis Model Mech | pmid:26035393 |